研究

2006年

2006年 主な論文業績

  1. Fujii T, Nomoto S, Koshikawa K, Yatabe Y, Teshigawara O, Mori T, Inoue S, Takeda S, Nakao A. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis. Hepatology. 2006 Jun;43(6):1267-75.
  2. Sakakibara T, Hibi K, Koike M, Fujiwara M, Kodera Y, Ito K, Nakao A. PAI-1 expression levels in esophageal and colorectal cancers are closely correlated to those in corresponding normal tissues. Anticancer Res. 2006 Nov-Dec;26(6B):4343-7.
  3. Morioka Y, Hibi K, Sakai M, Koike M, Fujiwara M, Kodera Y, Ito K, Nakao A. Aberrant methylation of the CHFR gene is frequently detected in non-invasive colorectal cancer. Anticancer Res. 2006 Nov-Dec;26(6B):4267-70.
  4. Kodera Y, Ito S, Fujiwara M, Mochizuki Y, Ohashi N, Ito Y, Nakayama G, Koike M, Yamamura Y, Nakao A. In vitro chemosensitivity test to predict chemosensitivity for paclitaxel, using human gastric carcinoma tissues. Int J Clin Oncol. 2006 Dec;11(6):449-53.
  5. Sugimoto H, Okochi O, Hirota M, Kanazumi N, Nomoto S, Inoue S, Takeda S, Nakao A. Early detection of liver failure after hepatectomy by indocyanine green elimination rate measured by pulse dye-densitometry. J Hepatobiliary Pancreat Surg. 2006;13(6):543-8.
  6. Fukuoka T, Hibi K, Nakao A. Aberrant methylation is frequently observed in advanced esophageal squamous cell carcinoma. Anticancer Res. 2006 Sep-Oct;26(5A):3333-5.
  7. Yokoyama H, Ikehara Y, Kodera Y, Ikehara S, Yatabe Y, Mochizuki Y, Koike M, Fujiwara M, Nakao A, Tatematsu M, Nakanishi H. Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis. Br J Cancer. 2006 Dec 4;95(11):1504-13.
  8. Fujiwara M, Kodera Y, Kasai Y, Miura S, Hibi K, Ito K, Akiyama S, Nakao A. Laparoscopy-assisted total gastrectomy for a case of MALT lymphoma: a case report. Hepatogastroenterology. 2006 Jul-Aug;53(70):648-50.
  9. Sugimoto H, Nakao A. Education and imaging. Hepatobiliary and pancreatic: Atrial kick and blood flow in hepatic veins. J Gastroenterol Hepatol. 2006 Nov;21(11):1752.
  10. Nakao A, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, Kodera Y, Inoue S, Takeda S. Oncological problems in pancreatic cancer surgery. World J Gastroenterol. 2006 Jul 28;12(28):4466-72. Review.
  11. Kimata H, Imai T, Kikumori T, Teshigahara O, Nagasaka T, Goshima F, Nishiyama Y, Nakao A. Pilot study of oncolytic viral therapy using mutant herpes simplex virus (HF10) against recurrent metastatic breast cancer. Ann Surg Oncol. 2006 Aug;13(8):1078-84.
  12. Komatsu Y, Hibi K, Kodera Y, Akiyama S, Ito K, Nakao A. TAOS1, a novel marker for advanced esophageal squamous cell carcinoma. Anticancer Res. 2006 May-Jun;26(3A):2029-32.
  13. Morioka Y, Hibi K, Sakai M, Koike M, Fujiwara M, Kodera Y, Ito K, Nakao A. Aberrant methylation of the CHFR gene in digestive tract cancer. Anticancer Res. 2006 May-Jun;26(3A):1791-5.
  14. Nakao A, Takeda S, Inoue S, Nomoto S, Kanazumi N, Sugimoto H, Fujii T. Indications and techniques of extended resection for pancreatic cancer. World J Surg. 2006 Jun;30(6):976-82; discussion 983-4.
  15. Nakao A, Fujii T, Sugimoto H, Kaneko T, Takeda S, Inoue S, Nomoto S, Kanazumi N. Is pancreaticogastrostomy safer than pancreaticojejunostomy? J Hepatobiliary Pancreat Surg. 2006;13(3):202-6. Review.
  16. Sakakibara T, Hibi K, Koike M, Fujiwara M, Kodera Y, Ito K, Nakao A. Plasminogen activator inhibitor-1 as a potential marker for the malignancy of gastric cancer. Cancer Sci. 2006 May;97(5):395-9.
  17. Kodera Y, Fujiwara M, Koike M, Nakao A. Chemotherapy as a component of multimodal therapy for gastric carcinoma. World J Gastroenterol. 2006 Apr 7;12(13):2000-5. Review.
  18. Yamada S, Nomoto S, Fujii T, Kaneko T, Takeda S, Inoue S, Kanazumi N, Nakao A. Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma. Eur J Surg Oncol. 2006 Apr;32(3):303-7.
  19. Ishiyama A, Hibi K, Koike M, Fujiwara M, Kodera Y, Ito K, Nakao A. PTCH gene expression as a potential marker for esophageal squamous cell carcinoma. Anticancer Res. 2006 Jan-Feb;26(1A):195-8.
  20. Hibi K, Nakao A. Lymph node metastasis is infrequent in patients with highly-methylated colorectal cancer. Anticancer Res. 2006 Jan-Feb;26(1A):55-8.
  21. Yokoyama H, Nakanishi H, Kodera Y, Ikehara Y, Ohashi N, Ito Y, Koike M, Fujiwara M, Tatematsu M, Nakao A. Biological significance of isolated tumor cells and micrometastasis in lymph nodes evaluated using a green fluorescent protein-tagged human gastric cancer cell line. Clin Cancer Res. 2006 Jan 15;12(2):361-8.
  22. Kodera Y, Nakanishi H, Ito S, Mochizuki Y, Ohashi N, Yamamura Y, Fujiwara M, Koike M, Tatematsu M, Nakao A. Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: analysis of real time reverse transcriptase-polymerase chain reaction after 5 years of followup. J Am Coll Surg. 2006 Feb;202(2):231-6.
  23. Hibi K, Kusugami K, Ina K, Ando T, Komatsu Y, Kodera Y, Ito K, Akiyama S, Nagasaka T, Goto H, Nakao A. Disseminated intravascular coagulation associated with systemic cytomegalovirus infection during cyclosporine therapy for ulcerative colitis: report of a case. Dis Colon Rectum. 2006 Jan;49(1):127-31.

このページの先頭へ